Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001221842 | SCV001393909 | pathogenic | not provided | 2023-12-14 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Cys493*) in the EYS gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in EYS are known to be pathogenic (PMID: 18836446, 20333770). This variant is present in population databases (no rsID available, gnomAD 0.003%). This variant has not been reported in the literature in individuals affected with EYS-related conditions. ClinVar contains an entry for this variant (Variation ID: 950186). For these reasons, this variant has been classified as Pathogenic. |
Revvity Omics, |
RCV003145415 | SCV003831043 | likely pathogenic | Retinitis pigmentosa 25 | 2022-11-08 | criteria provided, single submitter | clinical testing | |
Baylor Genetics | RCV003145415 | SCV004193540 | likely pathogenic | Retinitis pigmentosa 25 | 2024-02-22 | criteria provided, single submitter | clinical testing |